Project Community – empowering patients with cancer, survivors, advocates and consumers

• Conversations on Cancer – OCE’s public panel discussion series, making cancer personal

• National Black Family Cancer Awareness 

• Cancer Community Resources

A Message to Patients With Cancer and Health Care Providers About COVID-1

• Careers in Oncology/Hematology

• Project Socrates – an educational network for oncology product development

  • Project Livin' Label – labeling unfolded, knowledge released

  • OCE Regulatory Science Online Lecture Series – on-demand webinars about oncology product development and clinical trials

  • Interagency Oncology Task Force Fellowship

  • Summer Scholars  – virtual program for high-school students

• Project Facilitate – assisting oncology providers with expanded access requests

• Project Renewal – labeling updates for older oncology products

  • About Oncology Prescription Drug Labeling

  • How Do I Use Prescription Drug Labeling

  • Project Renewal FAQ

• Drug Information Soundcast in Clinical Oncology – short podcasts on oncology product approvals 

• OCE Partnerships During COVID-19

• Who We Are – Oncology Center of Excellence

• Oncology Regulatory Affairs – cross-center coordination of oncology product clinical review

  • Advancing Oncology Decentralized Trials – learning from COVID-19 trial datasets

  • Electronic Case Report Form Initiative – COVID-19-related data elements

  • OCE Assessment Aid

  • OCE Real-Time Oncology Review

  • Information for Sponsors – submissions to OOD

  • Project Point/Counterpoint – increasing transparency of viewpoints for the oncologic drugs advisory committee

  • Project Confirm – promoting the transparency of accelerated approval for oncology indications

• Project Orbis – concurrent submission and review of oncology products among international partners.

• Patient-Focused Drug Development Program – patient outcomes research in cancer populations

  • Project Patient Voice

• Pediatric Oncology Program – promoting development of drugs and biologics to treat cancer in children

  • Pediatric Oncology Drug Approvals

• Oncology Real World Evidence Program – fostering science and collaboration to translate real world data into real world evidence

  • Oncology Quality, Characterization and Assessment of Real-World Data (QCARD) Initiative

• Project Pragmatica – advancing evidence generation for approved oncology medical products

• Oncology Cell and Gene Therapy Program

• Immuno-Oncology Program 

• Precision Oncology Program 

• Rare Cancers Program – to promote the development of safe and effective new drugs and biologics to treat patients with rare cancers.  

• Project ASIATICA  - is an initiative to bring focus and awareness to Asian American, Native Hawaiian, and Other Pacific Islander (AA & NHPI) patients with cancer

• Project Catalyst – fostering early-stage product innovation

  • Oncology Regulatory Expertise and Early guidance (OREEG) – product-type advice to inform drug development decisions

• Project Equity – generating Evidence for diverse populations in oncology

• Project FrontRunner – Advancing Development of New Oncology Therapies to the Early Clinical Setting

• Project Optimus – is an initiative to reform the dose optimization and dose selection paradigm in oncology drug development 

• OCE Scientific Collaborative – applied research collaborations

  • OCE-Funded Active Extramural Research Projects

  • FDA Broad Agency Announcement: Frequently Asked Questions for Oncology Researchers

• Project Significant – promotes collaboration and engagement among diverse stake holders to further the design and analysis of cancer clinical trials with the goal to advance cancer therapies

• Project Silver – improving the evidence base for the treatment of older adults with cancer